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Objective To describe how menstrual cramps vary from cycle to cycle within a woman over time. 
To examine the influence of weight and lifestyle factors on occurrence, duration, and severity of 
menstrual pain. 
Design A one-year prospective menstrual diary study. 
Participants One hundred and sixty-five women aged 17 to 19 years entering a local university in 1985. 
Main outcome measures The occurrence, length, and maximum severity of pain during a menstrual 
period. 
Results Menstrual pain occurred during 7 1 ~ 6 %  of observed menstrual bleeds, most commonly beginning 
the first day of menses. The median duration was two days. Sixty percent of women reported at least 
one episode of severe pain, while 13% reported severe pain more than half the time. Earlier age at 
menarche and long menstrual periods increased the occurrence, duration and severity of pain. In 
smokers, cramps tended to last longer. Being overweight was an important risk factor for menstrual 
cramps and doubled the odds of having a long pain episode. Frequent alcohol consumption 
decreased the probability of having menstrual cramps, but in women who had pain it increased 
duration and severity. Physical activity was not associated with any pain parameter. 
Conclusions Women who have pain lasting three days are an important target group for prophylactic 
therapy. The occurrence and severity of menstrual cramps is influenced by potentially modifiable 
characteristics including weight, smoking, and alcohol consumption. Doctors may wish to counsel 
women presenting with dysmenorrhoea about the importance of healthy lifestyles and about the 
inefficacy of alcohol consumption as a treatment for dysmenorrhoea. 
INTRODUCTION 
Dysmenorrhoea is a common gynaecological com- 
plaint. In cross-sectional surveys, 30% to 60% of 
women of reproductive age report experiencing pain 
during menstruation with the proportion of women 
who report severe pain ranging from 7% to 15%l-13. 
Young adult women aged 17 to 24 years report a 
somewhat higher prevalence with estimates ranging 
from 67% to 72%1,479-12. Discrepancies between 
studies of prevalence are largely attributable to 
differences in the exact age of study populations and 
to variable definitions of dysmenorrhoea (e.g. any 
versus moderate pain, or ever versus usual experi- 
ence). Age at menar~hel,~?~?*, ~arity'3~3~, menstrual 
characteristics y 5 , 1  and ~ m o k i n g ~ , ~ , ~ J  3 ~ 1  have also 
been associated with the presence and severity of 
menstrual cramps. 
Correspondence: Dr S. D. Harlow, Department of Epidemiology, 
109 Observatory Street, Ann Arbor, Michigan 48109, USA. 
To date, no study has described how the occur- 
rence and severity of menstrual pain changes from 
cycle to cycle within a woman, and only one longitu- 
dinal study has prospectively examined change in the 
prevalence and severity of dysmenorrhoea within 
women over time8. Using data from menstrual diaries 
kept by a cohort of college women for one year, 
the present study describes how the experience of 
menstrual pain varies within women during the study 
period. We also prospectively examine how menstrual 
cycle characteristics, weight, and lifestyle factors 
influence the occurrence, duration, and severity of 
menstrual cramps and of menstrual disability. 
METHODS 
In 1985 women aged 17 to 19 years entering a local 
state university enrolled in a one-year menstrual 
diary study designed to evaluate the association 
between weight, physical activity and stress and 
menstrual cycle characteristics. Details of the study 
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methods have been presented e l ~ e w h e r e ~ ~ J ~ .  The 
study was approved by Institutional Review Boards 
at Johns Hopkins School of Hygiene and Public 
Health and at the local university from which partici- 
pants were recruited. Briefly, 766/908 women (84%) 
entering their freshmen year completed a screening 
questionnaire after giving informed consent to 
determine eligibility for the diary study. Women who 
were pregnant, were using birth control pills or other 
hormonal medications, had primary amenorrhoea or 
unknown menarche status were not eligible for the 
study. To increase homogeneity of the sample, two 
women who were married and had children were also 
excluded. No women reported using an intrauterine 
contraceptive device. Seventy-six percent of the 203 
ineligible women were not eligible because they were 
taking oral contraceptives. 
Of the 563 eligible women, 179 volunteered to 
participate within the first month of starting college 
and were enrolled in the diary study after again 
giving informed consent. The willingness of eligible 
women to participate was not related to menstrual 
characteristics or severity of menstrual cramps as 
reported on the screening questionnaire. No differ- 
ence between participants and nonparticipants was 
observed in their mean age of menarche (12-7 versus 
12.8 years; P = 0-31), mean reported average cycle 
length (28.6 versus 29.0 days; P = 0 ~ 5 7 ) ~  mean 
reported average bleed duration (4-9 versus 5-0 days; 
P = 0-46), history of having missed a cycle (40.8% 
versus 40.1%; P = 0.88), or the percentage reporting 
that their cycle length varied (56.4% versus 50.8%; 
P = 0.22). Usual severity of menstrual cramps 
also did not vary between participants and non- 
participants. Among participants 28.7% reported 
usually having no pain, 294% reported mild pain, 
275% moderate pain and 14.0% severe pain, 
compared with reports of 33*9%, 27.6%, 20.3% and 
18.2% in nonparticipants, respectively (P = 0.1 5). 
Eight women had started taking birth control pills 
at the time of enrolment, five never returned 
a monthly record, and one woman never reported a 
menstrual bleed, leaving 165 women eligible for this 
analysis. A woman’s record was censored when she 
dropped out of the study, when she became pregnant 
and continued the pregnancy, when she started using 
birth control pills or other hormonal medication, or at 
the end of the study year. Although the effect of oral 
contraceptives on menstrual pain is of interest, there 
are insufficient observations of women on the pill to 
address this question. Seventy-four women (45%) 
were censored prior to the end of the study year, half 
because they withdrew from the study and half 
because they started using hormonal contraception. 
One woman was censored because of pregnancy. All 
data until the time of censoring are used in this 
analysis. Duration of participation was not associated 
with length or mean severity of a pain event, 
but uncensored women had more opportunity to 
contribute an episode with a maximum pain level of 
five. The distribution of risk factors was similar 
between censored and uncensored women. 
At the time of enrolment, participants completed a 
questionnaire which obtained information on men- 
strual history and baseline weight, level of physical 
activity, perceived stress, dieting behaviour, alcohol 
consumption and smoking status. Throughout the 
course of the study, women maintained a daily record 
of their menstrual bleeding and experience of 
menstrual cramps or backache. Severity of menstrual 
pain was indicated by a score of 1 to 5, where 1 repre- 
sented minimal pain and 5 represented unbearable 
pain. After each bleeding episode women noted 
whether they had taken pills for pain, and if so what 
type, and whether they had missed school, work, or 
other activity. Self-administered questionnaires were 
completed monthly to obtain follow up information 
on risk factors, contraceptive use and pregnancy. 
Menstrual data 
Definitions recommended by the World Health 
Organisation were used to summarise the bleeding 
data”’. Menstrual cycle length was calculated by 
counting the number of days from the first day of one 
bleeding episode up to and including the day before 
the next bleeding episode. Length of a bleeding 
episode was calculated by counting the number of 
days from the start of a bleeding episode up to and 
including the day before the start of a bleeding-free 
interval. A bleeding-free interval was defined as 
consisting of no bleeding for at least two days. A 
bleeding episode could not consist of a single day of 
spotting (bleeding for which no protection was 
needed or bleeding that would fill less than one 
tampon or napkin). When a woman failed to return a 
monthly diary, all menstrual and pain variables were 
coded as missing. In this analysis, bleed length was 
categorised as one to seven days and more than seven 
days, menstrual history variables included age at 
menarche and history of having at least one 
menstrual cycle longer than six weeks. 
Menstrual pain data 
Examination of pain patterns showed that more than 
one discrete pain episode could be associated with 
the same bleeding episode. Therefore a pain event 
was defined as a group of linked pain episodes asso- 
ciated with the same bleeding episode in which the 
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pain-free interval between pain episodes was not 
more than four days. Pain episodes could begin 
before, during or after a bleeding episode or in the 
middle of a menstrual cycle unassociated with 
menstruation. After examining distributions of the 
timing of onset of pain events in relation to bleeding 
episodes, five days was the outside limit observed for 
a pain episode to start before and overlap the 
menstrual period. Thus pain episodes occurring 
within five days of or during a bleeding episode were 
considered to be bleed-associated. This analysis was 
limited to pain events associated with menstrual 
bleeding. For each pain event the following parame- 
ters were calculated: length, number of pain episodes, 
maximum level of pain reported, mean level of pain 
reported, the sum of the pain level for each pain day 
in an event, pain pattern (constant, increasing, 
decreasing and other) and the timing of onset (before, 
during, after the bleed). The length of a pain event 
was calculated by counting the number of days from 
the first day of pain in the first episode up to and 
including the last day of pain in the last episode. 
Measures of menstrual disability included whether a 
woman reported taking a pill for pain, and whether 
she had missed any activity or stayed in bed. 
Covariates 
Berm’s index18J9 was used as an index of weight 
corrected for height, with the appropriate power, 
based on self-reported weight and measured height, 
calculated to be 2.6. Smoking behaviour was defined 
by current smoking status (yedno). Frequency of 
alcohol consumption was categorised as infrequent 
(one drink or less per week) or frequent (two or more 
drinks per week). Perceived stress was measured 
using the four-item Perceived Stress Scale20. An 
additional measure of life stress was whether or not 
the student was living away from home. Although 
major life events were examined, neither loss events 
nor gain events were associated with any pain or 
disability parameter. Similarly, level of physical 
activity was not associated with pain or disability. 
Therefore neither variable is considered further here 
(data not shown). 
Analysis 
In order to describe the occurrence and severity of 
menstrual pain and associated disability, frequency 
distributions of pain parameters were calculated in 
two ways: 1. by giving equal weight to each observed 
pain event disregarding how many events were con- 
tributed by each woman (by-pain-event analysis) and 
2. by giving equal weight to each woman (by-woman 
analysis). For example, in the by-pain-vent analysis 
the mean length of all observed pain events or the 
proportion of all events in which pain medication was 
used is presented. In the by-woman analysis the mean 
of each woman’s mean pain length or the proportion 
of women who ever reported using pain medication is 
presented. In order to understand how length and 
severity of pain varied from one menstrual episode 
to the next within an individual, the probability of 
transition from one pain level to another in two 
consecutive menstrual periodP was estimated. 
Logistic regression with robust variance estima- 
tion21 (which accounts for the lack of independence 
between repeated observations in the same individ- 
ual) was used to model the probability of having or 
not having pain. A factor analysis identified three 
common factors, duration, severity and disability, 
from the observed pain variables. A second set of 
logistic regressions was used to model the probability 
of having long duration (pain for more than two days) 
or moderate/severe pain (a maximum pain level of 3 
or more), or missing an activity because pain had 
occurred. Logistic regression analyses were also used 
to model risk factors for medication use because of 
its clinical interest. Additional analyses examined 
three aspects of pain pattern: 1. decreasing versus 
other patterns, 2. multiple episodes in one pain event, 
and 3. the probability of pain onset prior to the onset 
of bleeding. Menstrual characteristics, examined as 
potential risk factors, included length of the preced- 
ing cycle and length of the concurrent bleeding 
episode. 
The covariate value assigned to a given pain event 
was the average value of that variable during the first 
14 days of the preceding menstrual cycle. Since 
covariate information was obtained during the 
previous menstrual cycle, only those bleeding 
episodes for which the preceding menstrual cycle 
was observed are included. Very short cycles are 
unlikely to actually be menstrual cycles and very 
long cycles represent a distinctly different ovarian 
process. Therefore, based upon our previous analysis 
of the distribution of menstrual cycle lengths in this 
dataset16, we excluded cycles shorter than 17 days 
(n = 17) or longer than 43 days (n = 60) were 
excluded. This paper thus analyses acute effects and 
addresses the question of how differences in the level 
of a risk factor at the start of a menstrual cycle effect 
the pain experience at the end of that cycle. 
RESULTS 
Age of menarche in the 165 eligible women ranged 
from 10 to 16, with a median age of 13 years. At 
enrolment, 43% reported a history of having had long 
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Table 1. Distribution of duration and severity of menstrual cramps (by-pain-event and by-woman) for 165 women aged 17-1 9 years old. Values 
are shown as n, mean (range), and 5th, 50th and 95th centiles. 
B y-pain-event B y-woman 
All bleeds 
Pain length 
Mean pain level 
Maximun pain level 
Bleeds with pain only 
Pain length 
Mean pain level 
Maximun pain level 
n Mean (Range) 5th 50th 95th n Mean (Range) 5th 50th 95th 
1393 1.7 ( e l l )  0 1 5 165 1.8* (CL7) 0 1.5 4.5 
1381 1.7 (&5) 0 2 4 165 1.7** (W) 0 2 3  
1381 2.1 ( e 5 )  0 2 5 165 3.57 ( G 5 )  0 4 5  
997 2.4 (1-11) 1 2 6 154 2.3 (1-7) 1 2 5  
985 2.9 (1-5) 1 3 5 154 3.8 (1-5) 1 4 5  
985 2.4 (1-5) 1 2.3 4 154 2.3 (1-4) 1 2.5 4 
*Mean of each woman’s mean length. **Mean of each woman’s mean level. tMean of each woman’s maximum level. 
cycles. Height ranged from 22-8 cm to 27.9 cm 
(median 25.3 cm). Weight at baseline ranged from 
38-2 kg to 95.5 kg (median 125 kg). Weight was rela- 
tively stable throughout the observation period, with 
the median monthly change in weight being 0 kg. In 
contrast to weight there was variation in perceived 
stress during the school year. The median monthly 
perceived stress score was 5 (maximum score = 12 
points). Only 20% of the women reported smoking at 
baseline and 19% reported drinking more than once 
per week. One hundred women lived away from 
home during at least one semester. 
Participants reported a median of nine bleeding 
episodes (range 1-15 episodes) for a total of 1396 
bleeding episodes. Median bleed duration was five 
days (range 1-19 days). Analyses which examined 
change in pain characteristics from bleeding episode 
to bleeding episode or which include information 
about risk factors required observation of at least two 
bleeds, and 145 women reported at least one bleed 
following a menstrual cycle of 17 to 43 days. 
Women reported a median of five discrete pain 
events (range 0-20 events) with pain reported during 
1000 (71.6%) of the 1396 observed bleeds. A pain 
event consisted of more than one discrete pain 
episode during 73 events, with a maximum of three 
episodes occurring during a given event. During 
three menstrual periods two distinct pain events were 
observed. Cramps most commonly began on the first 
day of menses (71.1% of pain events) and began 
before bleeding started in only 109 (10.9%) 
instances. The most commonly reported pain patterns 
were constant severity (45.6% of pain events) and 
decreasing severity (3 1 1 % of pain events). Eleven 
women never reported experiencing menstrual 
cramps. 
Table 1 presents descriptive statistics for the dura- 
tion and severity of pain episodes giving equal weight 
to each observation (by-pain+vent distribution) and 
giving equal weight to each woman (by-woman dis- 
tribution). Although pain events lasted up to 11 days, 
pain lasted five days or less in 95% of bleeding 
episodes with the median duration of dysmenorrhoea 
being two days, excluding bleeds without pain. Using 
the maximum pain score to define severity, pain was 
defined as mild in 37% (score = 1 or 2), moderate in 
30% (score = 3), and severe in 33% (score = 4 or 5) 
of reported pain events. Sixty percent of women 
reported at least one episode of severe pain, while 
13% reported having severe pain more than half the 
time. In the by-pain-vent distribution the median 
value for maximum pain was three, excluding bleeds 
without pain . In the by-woman distribution the 
median value for maximum pain level reported was 
four, which was consistent with the finding that most 
women in this study experienced at least one episode 
of severe pain. 
Table 2 presents the frequency of indicators 
of menstrual disability by-event and by-woman. 
Missing an activity, though experienced occasionally 
by many women, was an infrequent occurrence. 
Forty -two percent of the participants reported miss- 
ing either work, school, or another activity because 
of menstruation at some point during the study; 
however, an activity was missed during only 9.8% of 
bleeding episodes. Similarly, 37% of the women indi- 
cated that they had remained in bed during at least 
one bleeding episode, but bedrest only occurred 
during 10% of observed menstrual periods. Limitation 
of activity, when it occurred, generally lasted one day 
or less. Taking medication for pain was more 
common as 84% of women indicated that they 
had taken a pill for pain, with pain medication being 
used during 55% of observed menstrual periods. 
Acetaminophen, aspirin, and ibuprofen were the most 
frequently used medications, with each used in about 
a third of the medicated pain episodes. 
Severity and duration of pain tended to vary con- 
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Table 2. Frequency of reporting of missed activities and of taking a 
pain medication (by-pain-event and by-woman) for 165 women aged 
17 to 19 years old. Values are shown as n (“YO). 
By-pain-event By-woman (ever reported) 




















































siderably from menstrual period to menstrual period. 
Tables 3 and 4 present data on the probability of 
having a specified duration or severity during the cur- 
rent bleeding episode according to the level of pain in 
the previous bleeding episode. If a woman had no 
pain during her previous bleed, 45% of the time she 
would have no pain during her current menstrual 
period. If such a woman did experience pain, it was 
most likely to last only one to two days, but could be 
of any severity. Women who had had a pain event 
lasting three or more days previously were most 
likely to experience pain lasting two or more days 
during the subsequent menstrual period. Similarly, a 
woman who had previously experienced severe pain 
was most likely to experience moderate or severe 
pain during her subsequent menstrual period. 
Risk factors for menstrual pain 
Table 5 present the results of the multiple logistic 
regression analysis for the probability of having pain 
during a menstrual bleed. As would be expected, age 
at menarche, previous cycle length, and length of the 
current bleeding episode were all associated with 
having menstrual cramps. Pain was more likely to 
occur after longer menstrual cycles. Having a men- 
strual period longer than a week also increased a 
woman’s odds of experiencing pain by about 90%. 
There also appeared to be an important association 
between duration of bleed and age at menarche: in 
Table 3. Probability of having a pain event of zero, one, two, or more 
than two days during the current bleeding episode by duration of pain 
event in previous bleeding episode (by-woman transition probabili- 
tites for 165 women aged 17 to 19 years old). 
Duration of pain event during 
current bleeding episode Duration of pain 
event during previous 
bleeding episode No pain 1 day 2days ? 3  
No Pain 0.46 0.24 0.20 0.11 
1 0.28 0.33 0.27 0.13 
2 days 0.22 0.25 0.25 0.29 
? 3  0.16 0.13 0.33 0.38 
Table 4. Probability of having no, mild, moderate, or severe pain dur- 
ing the current bleeding episode by severity of pain event in previous 
bleeding episode (by woman transition probabilitites for 165 women 
aged 17 to 19 years old). 
Severity of pain during 
current bleeding episode Severity of pain 
during previous 
bleeding episode No pain Mild Moderate Severe 
No Pain 0.46 0.22 0.16 0.17 
Mild 0.27 0.32 0.23 0.18 
Moderate 0.18 025  0.29 0.28 
Severe 0.14 0.24 0.30 0.32 
women whose menarche began at age 11, the odds of 
having pain were increased threefold if their men- 
strual period exceeded seven days, compared with an 
increased odds of 70% if bleeding lasted seven days 
or less. Other than these menstrual characteristics, 
only two individual risk factors were associated with 
the probability of having pain: very heavy women 
had about a 75% increase in their odds of having 
menstrual cramps, while women who were frequent 
consumers of alcohol had about a 30% decrease. 
Table 6 presents the results of the analysis of risk 
factors for having moderate to severe pain or pain 
that lasted more than two days given the occurrence 
of menstrual cramps. In addition to their increased 
probability of having any pain, women with an ear- 
lier age at menarche had a slight increase in the odds 
of having more severe pain and a longer pain event. 
The odds of having a longer duration of pain were 
increased slightly in longer menstrual cycles, but 
long cycles were not associated with pain severity. 
Heavy women had more than twice the odds, and cur- 
rent smokers had a 50% increase in the odds, of hav- 
ing pain lasting more than two days. Although fie- 
quent alcohol consumption decreased the probability 
of having any pain, it appeared to increase the odds of 
having severe pain and pain lasting more than two 
days. Women living away from home were 50% less 
likely to experience severe pain. 
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Table 5. Multiple logistic regression with robust variance estimation 
on probability of having menstrual pain for 140 women aged 17 to 19 
years old. Values are given as odds ratios (OR) and 95% confidence 
intervals (CI). 
OR (95%CI) 
Menstrual cycle length (days) 
21 0.73 (0.5M.95) 
25 0.85 (0.75497) 
29 
35 1.27 (1.041.54) 
- 
42 1.67 (1.09-2.55) 
Bleed duration > 7 days 1.90 (1.29-2.80) 
Age at menarche (years) by bleed duration 
Bleed I 7 days 
11 1.77 (1.12-2.79) 
12 1.33 (1,061.67) 
13 
14 0.75 (0.60494) 
15 0.56 (0,36489) 
- 
Bleed > 7 days 
11 3.23 (1.92-544) 
12 1.80 (1.38-2.33) 
13 
14 0.56 (0.43472) 
15 0.31 (0.18452) 
90th Centile of weight-for-height 1.74 (0-724.20) 
- 
Alcohol consumed > once/week 0.76 (0.53-1.09) 
The major risk factor for taking pain medication 
was the severity and duration of a pain episode, with 
the odds of taking medication increased two and a 
half-fold (OR 2.53, 95% CI 1.85-3.45) during 
episodes of moderate to severe pain and 50% during 
long pain events (OR 1.54, 95% CI 1.10-2.11). 
Frequent alcohol consumption (OR 1.58) and a his- 
tory of long cycles (OR 1-68) also increased the odds 
of self-medication, although the confidence intervals 
include one. Similarly, the major determinant of 
missing an activity during the menstrual period was 
severity of cramps (OR 6.48, 95% CI 3-50-11.97), 
although women were less likely to miss an activity 
during periods of high stress (OR 0-54). 
Onset of cramps before bleeding was strongly 
associated with having an early age at menarche (OR 
1.54, 95% CI 1.05-2.26 for menarche at age 12 
versus age 13) and having a long menstrual cycle 
(OR 1-49, 95% CI 1.11-1-99 for 35 versus 29 days). 
After adjusting for age at menarche, bleed length, and 
menstrual cycle length, the probability of having pain 
begin before menstruation was associated with a 
history of having menstrual cycles longer than 43 
days (OR 1-60), smoking (OR 1.51), and being at the 
90th centile of perceived stress (OR 1-81, 95% CI 
Multiple pain episodes were most likely to occur 
during long bleeds (OR 3*21,95% CI 1.49-6.88) and 
were more common following long menstrual cycles 
1 -04-3- 1 5). 
Table 6. Multiple logistic regression with robust variance estimation 
on the probability (given the OccUtTeflCe of pain) that pain would be 
severe or last longer than two days in 130 women aged 17 to 19 years 
who experienced pain during at least one menstrual period. Values 
are given as odds ratios and 95% confidence intervals. 
Severe Pain Last > 2 days 
OR (95% CI) OR (95% CI) 
Age at menarche (years) 
11 1.43 (0.95-2.15) 1.38 (0.90-2.11) 
12 1.20 (0.97-1.47) 1.17 (0.95-1.45) 
- - 13 
14 0.84 (0.68-1.03) 0.85 (0.69-1.05) 
15 0.71 (0.46-1.06) 0.72 (0.47-1.11) 
Bleeding episode > 7 days 1.38 (0.83-2.31) 1.41 (0.89-2.24) 
Menstrual cycle length (days) 
21 0.79 (0.60-1.05) 
29 
25 0.89 (0.78-1.02) 
- 
35 1.19 (0.97-1.46) 
42 1.45 (0.93-2.28) 
Living away from home 0.67 (0*50-0*89) 
Alcohol consumed > once/week 1.38 (0.842.26) 1.95 (1.25-3.04) 
90th centile of weight-for-height 2.46(1.1&5.19) 
Smoker 1.52 (0.82-2.82) 
(OR 1-42, 95% CI 1.08-1436 for 35 versus 29 days). 
Afier adjusting for age at menarche, bleed length, and 
menstrual cycle length, the odds of a having multiple 
pain episodes were more than doubled in smokers 
(OR. 2.44, 95% CI 1.14-5.23), nearly doubled in 
heavy women (OR 1.9) and increased by more than 
50%, in women with a history of menstrual cycles 
more than 43 days in duration (OR 1-55), or above 
the 90th centile of weight-for-height (OR 1.69). 
Unusual pain patterns, in which pain increased dur- 
ing the bleeding episode rather than decreasing, were 
most common in heavy women (OR 1.70) and in 
women who lived away from home (OR 1.47, 95% 
CI 1 *05-2*05). 
DISCUSSION 
This study estimated the probability of recurrent 
severe dysmenorrhoea and identified risk factors for 
the occurrence of menstrual cramps, as well as risk 
factors associated with the severity and duration of a 
pain event in a cohort of 17 to 19 year old college 
women. An important finding is the association 
between being overweight and the occurrence and 
duration of menstrual cramps. Additional findings 
that menstrual cycle characteristics, smoking, and 
frequent alcohol consumption influenced pain experi- 
ence are consistent with previous findings from cross- 
sectional studies. Physical activity, which has been 
associated with a decreased prevalence of pain among 
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athletes22, but not in the general population6+*J2, also 
was not associated with pain in this study. 
Dysmenorrhoea is a common complaint and most 
women experience occasional episodes of severe 
pain. In this study 60% reported at least one episode 
of severe pain, a figure consistent with the 67% to 
72% prevalences observed in cross-sectional studies 
of 17 to 24 year old ~ornen~s"~. However, 13% of 
participants usually had severe pain, which is similar 
to the prevalence of severe pain reported in previous 
studies',". It is this group with severe pain who are 
most likely to benefit fiom prophylactic therapy. 
Data provided here on the probability of recurrent 
pain can assist clinicians in educating patients about 
menstrual cramps and provide usehl guidelines for 
recommending prophylactic use of antiprostaglandin 
therapies. Women who experience a pain episode 
lasting three or more days have a 72% probability of 
having pain lasting at least two days during their next 
menstrual period, and these women may be advised 
to start pharmacologic therapy when menstruation 
begins and to continue therapy throughout the first 
two to three days of their menstrual period. Although 
Pullon et aL6 found that more than half of adult 
women report menstrual cramps starting before men- 
struation, only 1 1 % of the young women in this study 
experienced the onset of pain before menstruation. 
Thus, starting medication with the onset of bleeding 
may be adequate for most adolescent women. 
Women who experience pain for two days have an 
equal probability of having either little to no pain or a 
long pain episode during their subsequent menstrual 
period. Doctors may wish to consider differences 
in individual levels of pain tolerance and patient 
attitudes towards medication in making recommen- 
dations about prophylactic therapy to this group of 
women. In either case, women who experience pain 
episodes lasting two to three days are an important 
group to target for discussions of effective pain man- 
agement. Similarly, women who experience a severe 
pain episode have a 62% probability of experiencing 
moderate to severe pain during their subsequent 
menstrual period and may also want to consider 
prophylactic therapy. 
It is well known that dysmenorrhoea is more likely 
to occur during ovulatory cycles and that, during the 
menarcheal transition, the probability of ovulation 
increases with age4>23924. Three studies of adult 
~ o m e n ' , ~ , ~  have also found an increased risk associ- 
ated with early age at menarche. In this study women 
with an earlier age at menarche were more likely to 
report pain, to have longer and more painful episodes 
and to report pain starting before bleeding. Longer 
duration of bleeding increased the probability of 
having pain, particularly in women with an earlier 
age at menar~he',~?'~, and of having longer, more 
severe pain or multiple pain episodes. The probability 
of having menstrual cramps, multiple pain episodes 
and onset of pain prior to bleeding also increased 
with length of the menstrual cycle. Thus, women who 
had menarche at age eleven or younger, who have 
cycles longer than 35 days or who experience periods 
lasting a week or longer might be counselled that 
they are more likely to experience menstrual pain. 
In addition to a woman's menstrual history, certain 
modifiable lifestyle characteristics appear to increase 
the risk of dysmenorrhoea, and doctors may want to 
discuss potential health benefits of lifestyle changes. 
Most importantly, cross-sectional studies of repro- 
ductive age women have found that the prevalence 
and severity3JQ of menstrual cramps are elevated in 
smokers. In one case-control study, smoking 10 or 
more cigarettes per day increased the odds of having 
moderatehevere dysmenorrhoea by about 90%14. In 
the current study only 5% of women smoked 10 or 
more cigarettes per day: Smoking was not associated 
with the probability of having pain , but among those 
with pain, smokers were more likely to have severe 
cramps, pain lasting longer than two days, multiple 
episodes of pain, and onset of pain before bleeding. 
The consistency of the literature on smoking suggests 
that use of tobacco is a risk factor for the occurrence 
of menstrual cramps and for prolonged pain 
 episode^^,*^. 
Parazzini et all4 reported that, compared with 
women who do not drink alcohol, women who drank 
one to seven glasses of alcohol per week were 
slightly more likely to have dysmenorrhoea (OR 1.3), 
while those who drank more than seven glasses of 
wine per week were slightly less likely to have 
dysmenorrhoea (OR 0.8). In our dataset consumption 
of alcohol more than once per week appeared to 
decrease the probability of having menstrual cramps, 
but among those experiencing pain, drinking doubled 
the odds of pain lasting more than two days. Frequent 
drinkers were also more likely to report self-medica- 
tion. Since alcohol appears to have both a suppressive 
and a potentiating action on dysmenorrhoea, women 
should probably be counselled against self-medica- 
tion with alcohol, and popular notions of the efficacy 
of alcohol should be questioned. 
Being overweight was also an important risk factor 
for the probability of experiencing pain and for 
increasing duration of pain, even after adjusting 
for cycle length and duration of bleed. Although 
being overweight is known to affect menstrual cycle 
length and the probability of a m e n ~ r r h e a ' ~ . ~ ~ ? ~ ~ ,  
no previous studies have identified weight as a poten- 
tial risk factor for dysmenorrhoea1*6*8. In this study 
the effect of being overweight was limited to the 
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90th centile of weight for height. Obesity may 
have an oestrogen mediated-effect on endometrial 
thickness or a prostaglandin-mediated effect on bleed 
efficiency. Heavy women report greater flows2* but 
also have shorter menstrual b l e e d ~ ~ ~ ~ ~ ~ .  In either case,
obese women may be another appropriate group for 
prophylactic therapy. 
The major limitation of this study was the lack of 
endocrinologic measures of ovarian activity to assess 
whether a given menstrual cycle was anovulatory. 
However, factors associated with anovulation, such 
as living away from home, did have the expected 
effect of reducing menstrual pain. Also, pain is a 
subjective phenomenon which can be difficult 
to measure accurately. In this study we tried to disag- 
gregate various pain parameters, including the occur- 
rence, amount, duration and pattern of pain, and 
to evaluate separately the impact of potential risk 
factors on each component. The possibility of biases 
resulting from censoring and from nonresponse 
of participants was considered, and neither initial 
willingness to participate in the diary study nor dura- 
tion of follow up was associated with a woman’s pain 
experience. Generalisation of the findings is limited 
by the restricted age range of the study population, 
but findings are consistent with those from older 
populations. Future studies should assess additional 
environmental risk factors, such as working 
conditions, noise, and diet31,32. 
In summary, this is the first prospective diary study 
of dysmenorrhoea. Many of the findings from previ- 
ous cross-sectional studies, including the importance 
of smoking as a risk factor, were replicated. Young 
women who experience menstrual pain lasting three 
or more days or who report severe pain are good 
candidates for prophylactic therapy. Doctors might 
recommend that these women begin appropriate 
pharmacologic treatment when menstruation begins 
and continue treatment for two days. The profile of 
young women at greatest risk of experiencing 
menstrual cramps are those women who reached 
menarche at age 11 or younger, with frequent cycles 
longer than 35 days or with bleeds lasting a week or 
longer, and who are overweight. Alcohol appears to 
increase the severity of menstrual cramps and should 
not be recommended as a treatment. 
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